PRKN and Parkinson disease: Thus, we evaluated mitochondrial phenotypes in Parkinson’s disease patients’ fibroblasts carrying mutations in PINK (I368N), PARK2 (R275W), and the most common Parkinson’s disease gene, LRRK2 (G2019S).